Guillain-Barré syndrome diagnostic criteria

Revision as of 14:10, 21 November 2012 by Charmaine Patel (talk | contribs) (Created page with "__NOTOC__ {{Guillain-Barré syndrome}} {{CMG}}; '''Associate Editors-In-Chief:''' Priyamvada Singh, MBBS [mailto:psingh13579@gmail.com] ==Overview== '''...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Guillain-Barré syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Guillain-Barré syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Guillain-Barré syndrome diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Guillain-Barré syndrome diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Guillain-Barré syndrome diagnostic criteria

CDC on Guillain-Barré syndrome diagnostic criteria

Guillain-Barré syndrome diagnostic criteria in the news

Blogs on Guillain-Barré syndrome diagnostic criteria

Directions to Hospitals Treating Guillain-Barré syndrome

Risk calculators and risk factors for Guillain-Barré syndrome diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]

Overview

Guillain-Barré syndrome (GBS) is an acute, autoimmune, polyradiculoneuropathy affecting the peripheral nervous system, usually triggered by an acute infectious process. It is included in the wider group of peripheral neuropathies.

Diagnostic criteria

  • Required
    • Progressive, relatively symmetrical weakness of 2 or more limbs due to neuropathy
    • Areflexia
    • Disease course < 4 weeks
    • Exclusion of other causes (see below)
  • Supportive
    • relatively symmetric weakness accompanied by numbness and/or tingling
    • mild sensory involvement
    • facial nerve or other cranial nerve involvement
    • absence of fever
    • typical CSF findings obtained from lumbar puncture
    • electrophysiologic evidence of demyelination from electromyogram

References

Template:WH Template:WS